Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma
G Fillet - Journal of Clinical Oncology, 2002 - orbi.uliege.be
Purpose: Randomized trial LNH93-3 was conducted on patients who had poor-prognosis
aggressive lymphoma and were younger than 60 years with two to three factors of the age …
aggressive lymphoma and were younger than 60 years with two to three factors of the age …
Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma
C Gisselbrecht, E Lepage, T Molina… - Journal of clinical …, 2002 - pubmed.ncbi.nlm.nih.gov
Purpose Randomized trial LNH93-3 was conducted on patients who had poor-prognosis
aggressive lymphoma and were younger than 60 years with two to three factors of the age …
aggressive lymphoma and were younger than 60 years with two to three factors of the age …
[引用][C] Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma
C GISSELBRECHT, E LEPAGE… - Journal of clinical …, 2002 - pascal-francis.inist.fr
Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive
lymphoma CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
lymphoma CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma.
C Gisselbrecht, E Lepage, T Molina… - Journal of Clinical …, 2002 - europepmc.org
Purpose Randomized trial LNH93-3 was conducted on patients who had poor-prognosis
aggressive lymphoma and were younger than 60 years with two to three factors of the age …
aggressive lymphoma and were younger than 60 years with two to three factors of the age …
Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma
C Gisselbrecht, E Lepage, T Molina… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: Randomized trial LNH93-3 was conducted on patients who had poor-prognosis
aggressive lymphoma and were younger than 60 years with two to three factors of the age …
aggressive lymphoma and were younger than 60 years with two to three factors of the age …
Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma
C Gisselbrecht, E Lepage, T Molina… - Journal of Clinical …, 2002 - cir.nii.ac.jp
< jats: p> PURPOSE: Randomized trial LNH93-3 was conducted on patients who had poor-
prognosis aggressive lymphoma and were younger than 60 years with two to three factors of …
prognosis aggressive lymphoma and were younger than 60 years with two to three factors of …
[PDF][PDF] Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma
C Gisselbrecht, E Lepage, T Molina, B Quesnel… - Journal of Clinical …, 2002 - Citeseer
Purpose: Randomized trial LNH93-3 was conducted on patients who had poor-prognosis
aggressive lymphoma and were younger than 60 years with two to three factors of the age …
aggressive lymphoma and were younger than 60 years with two to three factors of the age …
[PDF][PDF] Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma
C Gisselbrecht, E Lepage, T Molina… - Journal of Clinical …, 2002 - scholar.archive.org
Purpose: Randomized trial LNH93-3 was conducted on patients who had poor-prognosis
aggressive lymphoma and were younger than 60 years with two to three factors of the age …
aggressive lymphoma and were younger than 60 years with two to three factors of the age …
[PDF][PDF] Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma
C Gisselbrecht, E Lepage, T Molina, B Quesnel… - Journal of Clinical …, 2002 - Citeseer
Purpose: Randomized trial LNH93-3 was conducted on patients who had poor-prognosis
aggressive lymphoma and were younger than 60 years with two to three factors of the age …
aggressive lymphoma and were younger than 60 years with two to three factors of the age …
[引用][C] Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma
C GISSELBRECHT - J Clin Oncol, 2002 - cir.nii.ac.jp